News

Press ReleaseCGT Catapult leads industry consortium developing universal test to increase the safety and efficiency of stem cell therapies
Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2025202420232022 →
Cell and Gene Therapy Catapult opens manufacturing centre to accelerate growth of the industry in the UKCell and Gene Therapy Catapult opens manufacturing centre to accelerate growth of the industry in the UKRegulatory news - March 2018Regulatory news - March 2018Regulatory news - February 2018Regulatory news - February 2018Regulatory news - January 2018Regulatory news - January 2018Press release: CGT Catapult announces viral vector manufacturing technology collaboration with Freeline TherapeuticsPress release: CGT Catapult announces viral vector manufacturing technology collaboration with Freeline TherapeuticsGMP cell and gene therapy manufacturing in the UK: facilities, capabilities and capacityGMP cell and gene therapy manufacturing in the UK: facilities, capabilities and capacityPress release: CGT Catapult announces vector production agreement with AdaptimmunePress release: CGT Catapult announces vector production agreement with AdaptimmuneRegulatory news - December 2017Regulatory news - December 2017Regulatory news - November 2017Regulatory news - November 2017Quality Control in cell and gene therapy manufacturingQuality Control in cell and gene therapy manufacturingRegulatory news - October 2017Regulatory news - October 2017Innovation in operating models – the Cell and Gene Therapy Catapult manufacturing centreInnovation in operating models – the Cell and Gene Therapy Catapult manufacturing centre